Citi analyst Joanna Wuensch lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $35.00 (from $50.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Tandem Diabetes (TNDM) Tops Q4 EPS by 22c ; Offers GuidanceFebruary 26, 2025 4:30 PM Form 10-K TANDEM DIABETES CARE For: Dec 31February 26, 2025 4:10 PM Form 8-K TANDEM DIABETES CARE For: Feb 26February 26, 2025 4:07 PM Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial GuidanceFebruary 26, 2025 4:05 PM Canaccord Genuity Reiterates Buy Rating on Tandem Diabetes Care (TNDM) following Type 2 diabetes FDA clearanceFebruary 25, 2025 10:13 AM Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 DiabetesFebruary 25, 2025 8:32 AM Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 DiabetesFebruary 25, 2025 8:30 AM